ZEALAND PHARMA A/S earnings
Annual earnings per share (DKK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-03-31 | DKK -5.58 | DKK -5.58 | 2026-06-18T15:21:46Z |
| 2025 | 2025-03-31 | DKK -4.74 | DKK -4.74 | 2026-06-18T15:21:46Z |
Revenue & profit (DKK)
| Concept | 2026 | 2025 | 2025 |
|---|---|---|---|
| Revenue | DKK 34.0M | — | DKK 8.0M |
| Profit for the year | -DKK 394.0M | — | -DKK 335.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in ZEALAND PHARMA A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in DKK, as reported. Not investment advice.